JP Morgan Preview Podcast – Trovagene Oncology by Russo Partners published on 2020-01-07T14:35:56Z We’re counting down to the JP Morgan Conference by spotlighting the top technologies in healthcare about to be showcased in San Francisco. Today we profile Trovagene Oncology which is pioneering a KRAS-targeted therapy with the powerful potential to fight many cancers. Chief Scientific Officer Dr. Mark Erlander explains how it works.
